We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+29.23%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$3.12B
AUM Growth
+$391M
Cap. Flow
-$83.9M
Cap. Flow %
-2.69%
Top 10 Hldgs %
21.08%
Holding
271
New
22
Increased
49
Reduced
149
Closed
14

Top Buys

Rank Stock Value
1
SMTC icon
Semtech
SMTC
+$22.8M
2
AGX icon
Argan
AGX
+$19.8M
3
EVLV icon
Evolv Technologies
EVLV
+$19.1M
4
HIMS icon
Hims & Hers Health
HIMS
+$15.7M
5
CUBI icon
Customers Bancorp
CUBI
+$15.2M

Sector Composition

Rank Sector Weight
1 Technology 29.85%
2 Industrials 21.37%
3 Healthcare 21.06%
4 Financials 10.91%
5 Consumer Discretionary 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDFS icon
51
PDF Solutions
PDFS
$2.14B
$24.3M 0.78%
942,655
-11,706
-1% -$256K
ATEC icon
52
Alphatec Holdings
ATEC
$1.31B
$23.8M 0.76%
1,638,882
-45,452
-3% -$633K
TREE icon
53
LendingTree
TREE
$645M
$23.7M 0.76%
366,894
-15,084
-4% -$870K
AGX icon
54
Argan
AGX
$7.73B
$23.4M 0.75%
+86,532
New +$19.8M
MMSI icon
55
Merit Medical Systems
MMSI
$4.41B
$23.4M 0.75%
280,622
-11,168
-4% -$973K
CRS icon
56
Carpenter Technology
CRS
$27.7B
$23.3M 0.75%
94,819
-3,950
-4% -$1.01M
MDGL icon
57
Madrigal Pharmaceuticals
MDGL
$12.8B
$23.3M 0.75%
50,737
-2,371
-4% -$885K
COGT icon
58
Cogent Biosciences
COGT
$6.68B
$22.7M 0.73%
1,579,496
+133,722
+9% +$1.58M
COLL icon
59
Collegium Pharmaceutical
COLL
$1.17B
$22.4M 0.72%
639,694
-197,855
-24% -$6.88M
WVE icon
60
Wave Life Sciences
WVE
$1.12B
$21.9M 0.7%
2,996,900
-260,219
-8% -$2.11M
FOUR icon
61
Shift4
FOUR
$3.99B
$21.5M 0.69%
277,675
-5,329
-2% -$495K
FA icon
62
First Advantage
FA
$3.83B
$21.4M 0.69%
1,388,500
-43,231
-3% -$716K
FRPT icon
63
Freshpet
FRPT
$2.78B
$20.6M 0.66%
374,683
-146,492
-28% -$9.07M
NSSC icon
64
Napco Security Technologies
NSSC
$1.29B
$20M 0.64%
466,165
-53,595
-10% -$1.86M
EVLV icon
65
Evolv Technologies
EVLV
$1.02B
$19.8M 0.63%
+2,619,822
New +$19.1M
OSW icon
66
OneSpaWorld
OSW
$2.68B
$19.4M 0.62%
915,428
-9,835
-1% -$215K
CORT icon
67
Corcept Therapeutics
CORT
$9.72B
$19.3M 0.62%
232,452
-9,601
-4% -$695K
LTH icon
68
Life Time Group Holdings
LTH
$9.38B
$19M 0.61%
688,568
-14,159
-2% -$404K
CWAN
69
DELISTED
Clearwater Analytics
CWAN
$18.5M 0.59%
1,025,414
-46,893
-4% -$951K
NKTR icon
70
Nektar Therapeutics
NKTR
$2.31B
$18.4M 0.59%
+323,246
New +$10.7M
LIF
71
Life360
LIF
$4.36B
$18.1M 0.58%
170,529
-110,700
-39% -$9.32M
ARHS icon
72
Arhaus
ARHS
$1.09B
$17.8M 0.57%
1,678,309
-52,062
-3% -$548K
MTSI icon
73
MACOM Technology Solutions
MTSI
$20.4B
$17.8M 0.57%
143,085
-39,563
-22% -$5.22M
HIMS icon
74
Hims & Hers Health
HIMS
$7.6B
$17.4M 0.56%
+305,921
New +$15.7M
PWP icon
75
Perella Weinberg Partners
PWP
$1.16B
$17.1M 0.55%
803,654
+235,448
+41% +$5.03M

Similar funds

Emerald Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, Emerald Advisers held 271 positions worth $3.12B, up 14% from $2.73B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Emerald Advisers's Q3 2025 filing shows 22 new, 49 increased, 149 reduced and 14 closed positions. Its largest new stake was Semtech: 419,094 shares worth $29.9M. The largest sale was Credo Technology Group, an estimated $38.5M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Industrials and Healthcare.

  • Emerald Advisers's largest Q3 2025 buy was Semtech: 419,094 shares worth $29.9M.
  • Emerald Advisers added most to Bloom Energy in Q3 2025, an estimated $14.4M increase.
  • Emerald Advisers's biggest Q3 2025 reduction was Credo Technology Group, cutting an estimated $38.5M.
  • Emerald Advisers fully exited Chart Industries in Q3 2025, selling an estimated $17.9M.
  • Emerald Advisers's ten largest holdings make up 21% of its $3.12B portfolio in Q3 2025.
  • Emerald Advisers opened 22 new positions and closed 14 in Q3 2025.
  • Emerald Advisers's portfolio value rose 14% quarter-over-quarter to $3.12B.

Based on Emerald Advisers's 13F filing for Q3 2025, filed 30 Oct 2025.